BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9486180)

  • 1. Effect of intracisternal thyrotropin-releasing hormone on hepatic blood flow in rats.
    Tamori K; Yoneda M; Nakamura K; Makino I
    Am J Physiol; 1998 Feb; 274(2):G277-82. PubMed ID: 9486180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of central thyrotropin-releasing hormone on carbon tetrachloride-induced acute hepatocellular necrosis in rats.
    Sato Y; Yoneda M; Nakamura K; Makino I; Terano A
    J Hepatol; 2003 Jul; 39(1):47-54. PubMed ID: 12821043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of central thyrotropin-releasing hormone on pancreatic blood flow in rats.
    Goto M; Yoneda M; Nakamura K; Terano A; Haneda M
    Regul Pept; 2004 Sep; 121(1-3):57-63. PubMed ID: 15256274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin-releasing hormone in the dorsal vagal complex stimulates pancreatic blood flow in rats.
    Yoneda M; Goto M; Nakamura K; Yokohama S; Kono T; Tanamo M; Shimada T; Hiraishi H
    Regul Pept; 2005 Nov; 131(1-3):74-81. PubMed ID: 16040141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central thyrotropin-releasing hormone stimulates hepatic DNA synthesis in rats.
    Yoneda M; Tamori K; Sato Y; Yokohama S; Nakamura K; Kono T; Makino I
    Hepatology; 1997 Nov; 26(5):1203-8. PubMed ID: 9362363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central thyrotropin-releasing hormone increases hepatic cyclic AMP through vagal-cholinergic and prostaglandin-dependent pathways in rats.
    Yoneda M; Kono T; Watanobe H; Tamano M; Shimada T; Hiraishi H; Nakamura K
    Peptides; 2005 Sep; 26(9):1573-9. PubMed ID: 16112395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of central thyrotropin-releasing hormone analog on cerulein-induced acute pancreatitis in rats.
    Yoneda M; Goto M; Nakamura K; Shimada T; Hiraishi H; Terano A; Haneda M
    Regul Pept; 2005 Feb; 125(1-3):119-24. PubMed ID: 15582722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lafutidine increases hepatic blood flow via potentiating the action of central thyrotropin-releasing hormone in rats.
    Yoneda M; Kurosawa M; Watanobe H; Terano A
    J Gastroenterol Hepatol; 2003 Feb; 18(2):177-84. PubMed ID: 12542603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin-releasing hormone in the dorsal vagal complex stimulates hepatic blood flow in rats.
    Yoneda M; Hashimoto T; Nakamura K; Tamori K; Yokohama S; Kono T; Watanobe H; Terano A
    Hepatology; 2003 Dec; 38(6):1500-7. PubMed ID: 14647061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral mediators involved in gastric hyperemia to vagal activation by central TRH analog in rats.
    Király A; Sütö G; Guth PH; Taché Y
    Am J Physiol; 1998 Jan; 274(1):G170-7. PubMed ID: 9458786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central vagal activation by an analogue of TRH stimulates gastric nitric oxide release in rats.
    Saperas E; Mourelle M; Santos J; Moncada S; Malagelada JR
    Am J Physiol; 1995 Jun; 268(6 Pt 1):G895-9. PubMed ID: 7541945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracisternal TRH analogue RX 77368 stimulates gastric histamine release in rats.
    Yanagisawa K; Taché Y
    Am J Physiol; 1990 Oct; 259(4 Pt 1):G599-604. PubMed ID: 1699429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vagal regulation of gastric prostaglandin E2 release by central TRH in rats.
    Yoneda M; Taché Y
    Am J Physiol; 1993 Feb; 264(2 Pt 1):G231-6. PubMed ID: 8447405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms mediating gastric hyperemic and acid responses to central TRH analog at a cytoprotective dose.
    Király A; Sütó G; Guth PH; Taché Y
    Am J Physiol; 1997 Jul; 273(1 Pt 1):G31-8. PubMed ID: 9252506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of early gastric mucosal permeability induced by central thyrotropin-releasing hormone administration.
    Joh T; Oshima T; Takahashi N; Kaneko H; Sasaki M; Kataoka H; Watanabe K; Sobue M; Suzuki H; Nomura T; Ohara H; Itoh M
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G230-4. PubMed ID: 15499083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central thyrotropin-releasing factor analog prevents ethanol-induced gastric damage through prostaglandins in rats.
    Yoneda M; Taché Y
    Gastroenterology; 1992 May; 102(5):1568-74. PubMed ID: 1568566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of prostaglandins and calcitonin gene-related peptide in central vagal cholinergic-dependent protection against gastric injury in urethane-anesthetized rats.
    Kato K; Yang H; Taché Y
    Digestion; 1996; 57(5):322-7. PubMed ID: 8886575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nitric oxide in gastric hyperemia induced by central vagal stimulation.
    Tanaka T; Guth P; Taché Y
    Am J Physiol; 1993 Feb; 264(2 Pt 1):G280-4. PubMed ID: 8447409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracisternal injection of a TRH analogue stimulates gastric luminal serotonin release in rats.
    Stephens RL; Tache Y
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G377-83. PubMed ID: 2493198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracisternal PYY increases gastric mucosal resistance: role of cholinergic, CGRP, and NO pathways.
    Yang H; Kawakubo K; Taché Y
    Am J Physiol; 1999 Sep; 277(3):G555-62. PubMed ID: 10484380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.